Veterinary Medicines

Nafpenzal MC intramammárna suspenzia

Authorised
  • Benzylpenicillin sodium
  • Nafcillin
  • Dihydrostreptomycin
Download as PDF

Product identification

Medicine name:
Nafpenzal MC intramammárna suspenzia
Active substance:
  • Benzylpenicillin sodium
  • Nafcillin
  • Dihydrostreptomycin
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin sodium
    300000.00
    international unit(s)
    /
    1.00
    Syringe
  • Nafcillin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihydrostreptomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        7
        day
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • USKVBL
Authorisation number:
  • 96/251/92-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 18/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."